CITI Program Webinar Demo - IRB Review of Observational Research - YouTube

Channel: unknown

[0]
welcome everyone thank you for joining
[2]
us for today's citi program webinar
[4]
today's topic is irb review of
[7]
observational research and will be
[8]
presented by dr eileen willetts from the
[10]
icann school of medicine at mount sinai
[13]
just a few quick notes this webinar will
[15]
be recorded and the recording will be
[17]
available on the citi programs website
[20]
this webinar is for educational purposes
[22]
only it's not designed to provide legal
[24]
advice or legal guidance you should
[26]
consult with your organization's
[27]
attorneys if you have any questions or
[28]
concerns about relevant laws and
[30]
regulations that may be discussed in the
[32]
webinar in addition the views expressed
[34]
in the webinar are solely those of the
[36]
presenter
[37]
now let me tell you about today's
[39]
presenter dr eileen willetts is a
[41]
certified irb professional she's irb
[44]
chair at with the icann school of
[46]
medicine at mount sinai in new york
[48]
she's an associate professor in the
[49]
department of
[50]
environmental medicine and public health
[52]
an associate professor in the department
[54]
of global health and health systems
[56]
design at mount sinai and an adjunct
[58]
associate professor with the clarkson
[60]
university mount sinai program and
[62]
bioethics
[63]
as an irb chair dr willis provides
[65]
extensive regulatory support and
[67]
research ethics training to
[68]
investigators study personnel and
[70]
medical and graduate students
[72]
she also works with irb leadership to
[74]
develop institutional research policy
[77]
informed consent citizen science and
[79]
global health challenges rank at the
[80]
forefront of her current research
[82]
interests
[83]
now we can move on to the learning
[85]
objectives for this webinar they address
[87]
a number of aspects of observational
[89]
research studies and how irbs typically
[92]
review such protocols
[95]
this
[96]
webinar will identify the key
[99]
characteristics of the main types of
[101]
observational research studies cohort
[103]
studies cross-sectional and case control
[107]
the webinar will enable you to recognize
[109]
study risk in relation to the different
[111]
types of observational studies as well
[114]
as understand the kinds of study bias
[116]
associated with each observational
[118]
research design and apply the regulatory
[122]
review criteria to observational studies
[125]
for effective protocol review
[127]
and also in addition to these four
[129]
stated learning objectives as a result
[132]
of developing this presentation we've
[134]
decided to add two additional learning
[136]
objectives in blue and these will expand
[139]
and add depth to our discussion of irb
[142]
review
[143]
let's begin with an overview of
[145]
observational research i'll briefly
[148]
describe observational research study
[150]
designs and touch upon their strengths
[152]
and weaknesses including their
[154]
susceptibility for bias i'll then
[156]
discuss how irbs consider the primary
[159]
types of observational studies with
[161]
respect to the risk of subject harm
[164]
this risk determination is what drives
[166]
the type of irv review process whether a
[169]
study can be determined exempt from irb
[172]
review or be reviewed by the expedited
[175]
review process these are the basic
[178]
domains of observational study design
[180]
cross-sectional studies case control
[183]
studies retrospective cohort and
[185]
prospective cohort studies
[187]
each type of study has its own specific
[190]
design elements related to the timing of
[192]
assessments and sampling of study
[195]
subjects as well as advantages to study
[197]
conduct and the validity of research
[200]
findings
[201]
the rigor of each design and its
[203]
strength of evidence is indicated in
[205]
this pyramid
[207]
it illustrates that the prospective
[209]
cohort study is considered the most
[211]
rigorous and definitive design in terms
[214]
of the findings it can generate followed
[216]
by the retrospective cohort study case
[219]
control study and cross-sectional study
[222]
design
[223]
the reasons underlying the strength of
[225]
evidence categorization are more fully
[227]
explored in the city program course on
[230]
observational research so i will not get
[232]
into the weeds here and we'll keep the
[234]
discussion more about what an irb
[236]
reviewer should know regarding the
[239]
different design types so as to
[241]
effectively review an observational
[243]
research protocol
[249]
different observational study designs
[251]
may be prone to different types of
[253]
challenges or limitations
[255]
these can impact how you approach your
[257]
irb review and that is why it's
[260]
important to understand which study
[262]
design is being used within a given
[264]
protocol
[265]
for example
[267]
depending on the outcome of interest a
[269]
prospective cohort study can take years
[272]
to conduct and may require a large
[274]
sample size as some subjects will lose
[277]
interest in the research and drop out
[279]
some participants may be lost to
[281]
follow-up for reasons related to their
[283]
health status or their life circumstance
[286]
for this reason irb professionals should
[289]
question a seemingly small number of
[291]
study participants in a longitudinal
[293]
study
[295]
other observational study challenges
[297]
involve the inability to establish a
[299]
temporal sequence of events
[301]
this problem is specific to
[303]
cross-sectional studies because all data
[306]
are collected at a single point in time
[308]
and it can be difficult to determine
[310]
when a given variable precedes another
[313]
in time
[314]
lastly because observational studies are
[317]
by definition
[319]
non-experimental randomization or random
[322]
assignment is not part of the design
[325]
as it is in many clinical trials
[328]
the lack of randomization can yield
[330]
study groups that aren't
[332]
at this time in the context of the
[334]
aforementioned types of observational
[336]
study was let's consider how the irb
[339]
professional would approach protocol
[342]
review
[345]
one of the earliest assessments the irb
[347]
makes when reviewing a study involving
[349]
human subjects is whether the research
[352]
poses minimal risk of harm to subjects
[354]
or more than minimal risk of harm
[357]
here we see the regulatory definition of
[359]
minimal risk i'm sure most of you are
[361]
familiar with this
[363]
and many observational studies employ
[365]
research methods that are considered
[367]
minimal risk
[368]
for example
[369]
research involving focus groups surveys
[372]
or structured interviews
[374]
and studies in which data are collected
[376]
using using non-invasive measures such
[380]
as blood pressure venipuncture or mri
[384]
while one might not consider
[386]
observational research as having a high
[388]
degree of physical risk given that by
[391]
definition it does not involve an
[393]
intervention the risk of other types of
[396]
subject harm is possible and should be
[399]
considered during the course of irb
[401]
review
[404]
if we consider the risk of psychological
[406]
harm
[407]
a cross-sectional study involving an
[409]
in-depth interview in which study
[411]
participants are asked to recall
[413]
traumatic events for example domestic
[416]
violence can potentially cause distress
[419]
asking individuals to participate in
[422]
research activating such memories should
[425]
never be undertaken lightly
[428]
when reviewing observational research
[430]
involving sensitive lines of inquiry it
[433]
is good practice for the irb to ask the
[435]
investigator about the risk of
[437]
psychological harm and how it might be
[440]
deducted and addressed during the course
[443]
of the study
[444]
also
[445]
consider that observational studies
[448]
sometimes evaluate risky behaviors such
[451]
as unsafe sexual practices or drug use
[454]
the identification and disclosure
[457]
when a study first presents to you a
[459]
human research protection program the
[462]
first order of business is to identify
[464]
the appropriate level of review
[467]
here you can see four options
[469]
with respect to option one
[471]
a not human subject's research
[474]
determination
[475]
an activity is research not involving
[478]
human subjects if there is no
[480]
interaction or intervention with living
[482]
individuals and neither the provider of
[485]
the specimens or data nor the recipient
[488]
can link the specimens or data with
[491]
identifiable information individuals
[494]
either living or dead
[496]
an observational study involving a fully
[499]
de-identified publicly available data
[501]
set with no investigator access to
[504]
identifiers could conceivably be
[506]
considered not human subjects research
[510]
similarly should an investigator be
[512]
provided with bio specimens with
[515]
absolutely no links back to the subject
[518]
this activity could fit an nhsr
[521]
classification
[523]
however
[524]
more often than not there exists the
[526]
potential to link data back to the
[529]
individual and the irb professional will
[532]
select exempt category 4 to best
[534]
classify the research
[537]
many observational research studies that
[539]
present to the irb are no greater than
[542]
minimal risk and will qualify for either
[544]
an irb exemption or the expedited review
[548]
process
[550]
when might an observational study be
[552]
deemed exempt
[554]
exempt in summary there are three main
[557]
types of observational study designs
[560]
each is non-interventional and
[562]
characterized by the direction and
[564]
timing of data collection
[566]
the irb may deem an observational study
[569]
exempt or elect to review it by the
[571]
expedited review process or by convened
[574]
committee most but not all observational
[578]
research is considered minimal risk and
[581]
will undergo expedited review or will
[584]
fit into an exempt category
[587]
irbs can approve waivers of consent and
[589]
hipaa authorization for observational
[592]
research when certain criteria are met
[595]
irbs apply the 111 criteria to the
[598]
review of observational research
[601]
i also invite everyone to review our
[603]
content offerings regularly as we are
[606]
continually adding new courses and
[608]
webinars and various areas of research
[610]
ethics compliance and professional
[611]
development